StockNews.com Begins Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Shares of SRNE stock opened at $0.00 on Thursday. Sorrento Therapeutics has a 52 week low of $0.00 […]
Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Shares of SRNE stock opened at $0.00 on Thursday. Sorrento Therapeutics has a 52 week low of $0.00 […]
